Targeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines

Outcome in high-risk patients with refractory or relapsed germ cell tumours (GCT) remains poor. Novel strategies enhancing therapeutic efficacy whilst limiting therapeutic burden are warranted, yet immunotherapy approaches geared towards activating endogenous antitumor responses have not been succes...

Descripción completa

Detalles Bibliográficos
Autores principales: Schönberger, Stefan, Kraft, Daniela, Nettersheim, Daniel, Schorle, Hubert, Casati, Anna, Craveiro, Rogerio B., Mohseni, Mahsa Mir, Calaminus, Gabriele, Dilloo, Dagmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281168/
https://www.ncbi.nlm.nih.gov/pubmed/32438548
http://dx.doi.org/10.3390/cancers12051279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281168/
https://www.ncbi.nlm.nih.gov/pubmed/32438548
http://dx.doi.org/10.3390/cancers12051279

Ejemplares similares